Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymorphism of disopyramide.

S R Gunning, M Freeman, J A Stead

    The Journal of Pharmacy and Pharmacology
    |October 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Disopyramide exhibits two crystal forms with no significant bioavailability differences. Solid-state transformation kinetics between Form I and Form II were analyzed, revealing a high activation energy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Narrowing the care and treatment gap through a human resources for mental health plan: Key considerations.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same author

    Upskilling clinicians in compression therapy for leg ulcers - "Planet Compression Day" initiative.

    Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing·2025
    Same author

    First Demonstration of Improved Fusion Yield with Increased Compression through Reduced Adiabat in Inertial Confinement Fusion Experiments at the National Ignition Facility.

    Physical review letters·2025
    Same author

    Optically multiplexed neutron time-of-flight technique for inertial confinement fusion.

    The Review of scientific instruments·2024
    Same author

    Spot size measurement of a deuterium-tritium dense plasma focus using neutron radiography.

    The Review of scientific instruments·2024
    Same author

    Observations and properties of the first laboratory fusion experiment to exceed a target gain of unity.

    Physical review. E·2024
    Same journal

    Norisoboldine suppresses epithelial-mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Development, characterization, and therapeutic evaluation of uniform dezocine-loaded PLGA microspheres for sustained analgesia and cognitive protection.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Phytochemical constituents, biological activities, toxicological profiles, and current applications of Muntingia calabura L.: an updated review.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Uterine relaxant effects of Ageratum conyzoides essential oil: influence of hormonal status and calcium modulation.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Liraglutide-mediated protection against ethanol-induced gastric ulcer in male and female rats: enhancement of mucosal defense, anti-inflammatory and antioxidant mechanism.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Exploring the mechanism of action of Qufengzhitong pills in treating rheumatoid arthritis via the PI3K/AKT, NF-κB, and MAPK pathways.

    The Journal of pharmacy and pharmacology·2026
    See all related articles

    Area of Science:

    • Pharmaceutical sciences
    • Solid-state chemistry
    • Physical chemistry

    Background:

    • Disopyramide is an antiarrhythmic drug.
    • Polymorphism, the ability of a solid material to exist in multiple crystal forms, can impact drug properties.
    • Understanding crystal forms is crucial for drug development and formulation.

    Purpose of the Study:

    • To characterize two distinct crystal forms of disopyramide.
    • To investigate the solid-state transformation kinetics between these forms.
    • To assess the impact of polymorphism on disopyramide bioavailability.

    Main Methods:

    • X-ray diffraction for crystal structure determination.
    • Differential scanning calorimetry for thermal analysis.
    • Infrared spectroscopy for molecular characterization.

    Related Experiment Videos

  • Prout-Tompkins theory for solid-state reaction kinetics analysis.
  • Main Results:

    • Two crystal forms of disopyramide (Form I and Form II) were successfully characterized.
    • The solid-state transformation from Form I to Form II was analyzed, yielding an activation energy of 144 kJ mol-1.
    • Dissolution profiles and plasma concentrations indicated no significant bioavailability differences between the two polymorphs.

    Conclusions:

    • Disopyramide polymorphism does not appear to affect its bioavailability.
    • The solid-state transformation between disopyramide forms is an energy-intensive process.
    • These findings support the potential for interchangeable use of disopyramide polymorphs in pharmaceutical formulations.